The central cannabinoid receptor type-2 (CB2) and chronic pain

被引：29
|
作者：
Shang, Yuchao [1 ,2 ]
Tang, Yuying [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp 2, Dept Anesthesiol, Chengdu, Peoples R China
[2] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 2017年 / 127卷 / 09期
基金：
中国国家自然科学基金;
关键词：
Cannabinoid; CB2; pain; analgesia; clinical; RANDOMIZED CONTROLLED-TRIAL; CHRONIC NEUROPATHIC PAIN; INCREASES INTRACELLULAR CALCIUM; ACTIVATED PROTEIN-KINASE; SPINAL DORSAL-HORN; MULTIPLE-SCLEROSIS; GLIAL ACTIVATION; NERVE INJURY; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO;
D O I：
10.1080/00207454.2016.1257992
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Cannabinoid receptor type-2 (CB2, CB2 receptor or CB2-R) mediates analgesia via two mechanisms. CB2 receptors contained in peripheral immune tissue mediate analgesia by altering cytokine profiles, and thus have little adverse effects on central nervous systems (CNSs). CB2 is also expressed in the neurons and glial cells of the CNS. This neuronal expression may also contribute to pain attenuation. The CB2 receptor has been proposed as a potential target in treating chronic pain of several etiologies.
引用
收藏
页码：812 / 823
页数：12
相关论文
共 50 条
  • [21] Targeting the cannabinoid CB2 receptor:: Mutations, modeling and development of CB2 selective ligands
    Raitio, KH
    Salo, OMH
    Nevalainen, T
    Poso, A
    Järvinen, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (10) : 1217 - 1237
  • [22] Cholesterol as a modulator of cannabinoid receptor CB2 signaling
    Yeliseev, Alexei
    Iyer, Malliga R.
    Joseph, Thomas T.
    Coffey, Nathan J.
    Cinar, Resat
    Zoubak, Lioudmila
    Kunos, George
    Gawrisch, Klaus
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] Expression of CB2 cannabinoid receptor in Pichia pastoris
    Feng, W
    Cai, H
    Pierce, WM
    Song, ZH
    PROTEIN EXPRESSION AND PURIFICATION, 2002, 26 (03) : 496 - 505
  • [24] The cannabinoid receptor CB2 is not associated with myocardial infarction
    Reinhard, W.
    Stark, K.
    Baessler, A.
    Fischer, M.
    Sedlacek, K.
    Hengstenberg, C.
    EUROPEAN HEART JOURNAL, 2007, 28 : 106 - 107
  • [25] Cannabinoid Receptor CB2 Oligomerization in a Lipid Matrix
    Yeliseev, Alexei
    Nickels, Jonathan D.
    Hines, Kirk G.
    Zoubak, Lioudmila
    Teague, Walter E., Jr.
    Lynch, Diane L.
    Hurst, Dow P.
    Weiss, Kevin L.
    Katsaras, John
    Reggio, Patricia H.
    Gawrisch, Klaus
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 234A - 234A
  • [26] Editorial: Therapeutic potential of the cannabinoid CB2 receptor
    Smoum, Reem
    Grether, Uwe
    Karsak, Meliha
    Vernall, Andrea J.
    Park, Frank
    Hillard, Cecilia J.
    Pacher, Pal
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] The cannabinoid CB2 receptor:: a good friend in the gut
    Izzo, A. A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (09): : 704 - 708
  • [28] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [29] Crystal Structure of the Human Cannabinoid Receptor CB2
    Li, Xiaoting
    Hua, Tian
    Vemuri, Kiran
    Ho, Jo-Hao
    Wu, Yiran
    Wu, Lijie
    Popov, Petr
    Benchama, Othman
    Zvonok, Nikolai
    Locke, K'ara
    Qu, Lu
    Han, Gye Won
    Iyer, Malliga R.
    Cinar, Resat
    Coffey, Nathan J.
    Wang, Jingjing
    Wu, Meng
    Katritch, Vsevolod
    Zhao, Suwen
    Kunos, George
    Bohn, Laura M.
    Makriyannis, Alexandros
    Stevens, Raymond C.
    Liu, Zhi-Jie
    CELL, 2019, 176 (03) : 459 - +
  • [30] Cannabinoid Receptor CB2 Modulates Axon Guidance
    Duff, Gabriel
    Argaw, Anteneh
    Cecyre, Bruno
    Cherif, Hosni
    Tea, Nicolas
    Zabouri, Nawal
    Casanova, Christian
    Ptito, Maurice
    Bouchard, Jean-Francois
    PLOS ONE, 2013, 8 (08):
12345